Latest news
Debiopharm International SA initiates clinical phase II study evaluating Debio 1450 in Staphylococcal skin infections
Debiopharm International SA announces results of 2 key oncology programs at 2015 AACR Conference
Debiopharm Diagnostics leads investment round in GenePOC with Emerillon Capital
FDA Grants Fast Track designation to Debiopharm Group’s antibiotic Debio 1450
Debiopharm Investment, Ardian, Nixdorf Foundation and Bernis today acquire Eco Delta solar activities
Debiopharm Investment becomes a minority shareholder in Haut-Lac International Bilingual School in St-Légier (VD)
Debiopharm Group™ presents advances of two key oncology clinical programs at the 26th EORTC-NCI-AACR symposium in Barcelona
Coorpacademy, établi à l’EPFL et l’un des leaders des MOOCs à destination des entreprises, lève 3,2 millions d’euros auprès de…